Models for the study of Clostridium difficile infection.
about
Interactions Between the Gastrointestinal Microbiome and Clostridium difficileMurine models to study Clostridium difficile infection and transmissionFate of ingested Clostridium difficile spores in miceShort-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human diseaseCefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile.In vivo assessment of SMT19969 in a hamster model of clostridium difficile infection.Efficient gene targeting in golden Syrian hamsters by the CRISPR/Cas9 system.The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tractHumanized microbiota mice as a model of recurrent Clostridium difficile diseaseClostridium difficile drug pipeline: challenges in discovery and development of new agentsBacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.A novel regulator controls Clostridium difficile sporulation, motility and toxin productionClostridium difficile colonization and antibiotics response in PolyFermS continuous model mimicking elderly intestinal fermentation.Antibiotics and the Intestinal Microbiome : Individual Responses, Resilience of the Ecosystem, and the Susceptibility to Infections.'Get in Early'; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages.Toxin-positive Clostridium difficile latently infect mouse colonies and protect against highly pathogenic C. difficile.Improving the reproducibility of the NAP1/B1/027 epidemic strain R20291 in the hamster model of infection.SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut modelFidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.The pangenome of the genus Clostridium.Antibiotic treatments and microbes in the gut.Evaluating the effect of Clostridium difficile conditioned medium on fecal microbiota community structure.Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.Acute infection of mice with Clostridium difficile leads to eIF2α phosphorylation and pro-survival signalling as part of the mucosal inflammatory response.Treatment of Clostridium difficile infection with a small molecule inhibitor of toxin UDP-glucose hydrolysis activity.Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.Mixed infection by Clostridium difficile in an in vitro model of the human gutThe C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37
P2860
Q26778722-C8232FC0-3BCD-42D6-8480-0032F3133AD9Q26859965-4065A174-EBFB-4AC3-A73B-61A8AE7779ABQ27308882-27A6D01C-36C2-43C7-8141-D3C9F98B4235Q28703592-953526BA-FE8B-4E7B-9388-9DC9F8C2C8B7Q30834661-437F3E3C-9088-45E3-B1E4-5CD7B8741C06Q34298535-B0A5A554-A4B8-4786-AB4F-4AFEAB4A17FDQ34299171-8FD85632-0E20-4BCC-BB91-892FB4F1BB7BQ34316807-A4FED726-DB80-4792-BBF3-DF49CF0470AEQ34623572-9DA848C5-2AB8-4C10-B11C-65D7F1DA6768Q35098142-BB4BB170-124B-487C-A7A7-92A3A7EC5207Q35750753-6081889A-0F52-4345-BFD0-C12883142F96Q35846436-81572FC2-05BF-4686-B24C-6FAD2AA4FBE1Q36571896-14C95AD5-A715-4D53-9CBB-82C794B12A3AQ36984805-B46FC7FD-B643-4D0F-8A34-78A024CF00C5Q37465285-BB171E6C-BDD4-45DC-9328-C3A5F5077048Q38980008-957D35F6-E093-45F8-96F7-2F7C4BAE72F3Q39388122-52CC1D89-66A4-4FF2-BB3B-BDA962602971Q40324807-909E9BA0-6F09-4108-AB85-90190B7D0A11Q40766451-9C05F35C-0A23-4CE8-83BC-127FEE51B357Q41148853-8B3D6C40-6730-4F74-9D4E-B97AF02452DFQ41752763-2ECB597B-A1BB-4658-B9A4-D411BAC46D35Q41834229-5B5F8E93-FE0F-4337-A6CC-DD47A9674B98Q42697422-E3580E1C-BF7F-4246-9A45-436B001ED126Q46400900-63E9B067-DBD0-41B5-A690-92C16F145488Q46940081-7DA78E24-3FD8-4E57-AEFD-2C851F14FFBBQ47119137-83A031B9-56D0-4F00-A399-5E16FB2B774CQ50026548-3E34A6BA-F4FE-4175-BD2C-98B539B133F2Q50041908-77609CB6-4503-4FDB-B2D1-1738B5CC79E8Q50998497-B8FFD86C-D128-461D-864B-51BEC12A89A0Q51730586-CBDD8128-CDCC-4F07-9DCE-9236BEA3D0AFQ52839693-19095815-5388-407D-B1F4-C04C5DA579FAQ56833316-75D36C2C-DB2E-4A21-8F7C-EBE9002E0927Q58734424-B0934A7E-D878-4CED-8EFE-57A9F8E97595
P2860
Models for the study of Clostridium difficile infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Models for the study of Clostridium difficile infection.
@ast
Models for the study of Clostridium difficile infection.
@en
Models for the study of Clostridium difficile infection.
@en-gb
type
label
Models for the study of Clostridium difficile infection.
@ast
Models for the study of Clostridium difficile infection.
@en
Models for the study of Clostridium difficile infection.
@en-gb
prefLabel
Models for the study of Clostridium difficile infection.
@ast
Models for the study of Clostridium difficile infection.
@en
Models for the study of Clostridium difficile infection.
@en-gb
P2860
P356
P1433
P1476
Models for the study of Clostridium difficile infection.
@en
P2093
Emma L Best
P2860
P304
P356
10.4161/GMIC.19526
P577
2012-03-01T00:00:00Z